The DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Human beta cell mass and function in diabetes: Recent advances in knowledge and technologies to understand disease pathogenesis
Open accessAbstract
BACKGROUND: Plasma insulin levels are predominantly the product of the morphological mass of insulin producing beta cells in the pancreatic islets of Langerhans and the functional status of each of these beta cells. Thus, deficiency in either beta cell mass or function, or both, can lead to insufficient levels of insulin, resulting in hyperglycemia and diabetes. Nonetheless, the precise contribution of beta cell mass and function to the pathogenesis of diabetes as well as the underlying mechanisms are still unclear. In the past, this was largely due to the restricted number of technologies suitable for studying the scarcely accessible human beta cells. However, in recent years, a number of new platforms have been established to expand the available techniques and to facilitate deeper insight into the role of human beta cell mass and function as cause for diabetes and as potential treatment targets. SCOPE OF REVIEW: This review discusses the current knowledge about contribution of human beta cell mass and function to different stages of type 1 and type 2 diabetes pathogenesis. Furthermore, it highlights standard and newly developed technological platforms for the study of human beta cell biology, which can be used to increase our understanding of beta cell mass and function in human glucose homeostasis. MAJOR CONCLUSIONS: In contrast to early disease models, recent studies suggest that in type 1 and type 2 diabetes impairment of beta cell function is an early feature of disease pathogenesis while a substantial decrease in beta cell mass occurs more closely to clinical manifestation. This suggests that, in addition to beta cell mass replacement for late stage therapies, the development of novel strategies for protection and recovery of beta cell function could be most promising for successful diabetes treatment and prevention. The use of today's developing and wide range of technologies and platforms for the study of human beta cells will allow for a more detailed investigation of the underlying mechanisms and will facilitate development of treatment approaches to specifically target human beta cell mass and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–221 of 221
HUMAN PERIPHERAL BLOOD LYMPHOCYTE RECONSTITUTED SEVERE COMBINED IMMUNODEFICIENT (hu-PBL-SCID) MICE
Shiroki, R., Poindexter, N. J., Woodle, E. S., Hussain, M. S., Mohanakumar, T., & Scharp, D. W. (1994) · Transplantation · doi:10.1097/00007890-199457110-00004 · Cited by 38
Arystarkhova, E., Liu, Y. B., Salazar, C. A., Stanojevic, V., Clifford, R. J., Kaplan, J. H., Kidder, G. M., & Sweadner, K. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401190 · Cited by 35
Genetically Engineered Human Islets Protected From CD8-mediated Autoimmune Destruction In Vivo
Zaldumbide, A., Alkemade, G. M., Carlotti, F., Nikolić, T., Abreu, J. R. F., Engelse, M. A., Skowera, A., de Koning, E. J. P., Peakman, M., Roep, B. O., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.105 · Cited by 34
HUMAN PERIPHERAL BLOOD LYMPHOCYTE RECONSTITUTED SEVERE COMBINED IMMUNODEFICIENT (hu-PBL-SCID) MICE
Shiroki, R., Poindexter, N. J., Woodle, E. S., Hussain, M. S., Mohanakumar, T., & Scharp, D. W. (1994) · Transplantation · doi:10.1097/00007890-199406150-00004 · Cited by 34
Nyblom, H. K., Bugliani, M., Fung, E., Boggi, U., Zubarev, R., Marchetti, P., & Bergsten, P. (2009) · Journal of Proteome Research · doi:10.1021/pr9006816 · Cited by 33
Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation
Eriksson, O., Selvaraju, R., Eich, T., Willny, M., Brismar, T., Carlbom, L., Ahlström, H., Tufvesson, G., Lundgren, T., & Korsgren, O. (2016) · Diabetes · doi:10.2337/db16-0222 · Cited by 29
Mezghenna, K., Pomiès, P., Chalançon, A., Castex, F., Leroy, J., Niclauß, N., Nadal, B., Cambier, L., Cazevieille, C., Petit, P., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2264-8 · Cited by 28
Characterization of residual β cell function in long‐standing type 1 diabetes
Sherr, J. L., Ghazi, T., Wurtz, A., Rink, L., & Herold, K. C. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2478 · Cited by 27
Lupi, R., Marselli, L., Dionisi, S., Guerra, S. D., Boggi, U., Chiaro, M. D., Lencioni, C., Bugliani, M., Mosca, F., Mario, U. D., et al. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.460 · Cited by 27
Meier, R. P. H., Seebach, J. D., Morel, P., Mahou, R., Borot, S., Giovannoni, L., Parnaud, G., Montanari, E., Bosco, D., Wandrey, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091268 · Cited by 26
Fransson, M. E., Brännström, J., Duprez, I. R., Essand, M., Blanc, K. L., Korsgren, O., & Magnusson, P. U. (2015) · Regenerative Medicine Research · doi:10.1186/s40340-015-0010-9 · Cited by 26
Functional MRI characterization of isolated human islet activation
Leoni, L., Serai, S., Magin, R., & Roman, B. (2010) · NMR in Biomedicine · doi:10.1002/nbm.1542 · Cited by 25
Pancreatic β‐cell mass or β‐cell function? That is the question!
Henquin, J., Cerasi, E., Efendić, S., Steiner, D. F., & Boîtard, C. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00968.x · Cited by 24
Ehehalt, F., Sturm, D., Rösler, M., Distler, M., Weitz, J., Kersting, S., Ludwig, B., Schwanebeck, U., Saeger, H., Solimena, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134140 · Cited by 22
Botsikas, D., Terraz, S., Vinet, L., Lamprianou, S., Becker, C. D., Bosco, D., Meda, P., & Montet, X. (2012) · Islets · doi:10.4161/isl.20857 · Cited by 22
Alterations in the Patterns of Insulin Secretion Before and After Diagnosis of IDDM
O’Meara, N., Sturis, J., Herold, K. C., Ostrega, D., & Polonsky, K. S. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.568 · Cited by 22
Kaas, A., Andersen, M. L. M., Fredheim, S., Hougaard, P., Buschard, K., Petersen, J. S., de Beaufort, C. E., Robertson, K. J., Hansen, L., Mortensen, H. B., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00812.x · Cited by 21
Berclaz, C., Schmidt-Christensen, A., Szlag, D., Extermann, J., Hansen, L., Bouwens, A., Villiger, M., Goulley, J., Schuit, F. C., Grapin‐Botton, A., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3819-x · Cited by 19
Andersson, C. K., Carlsson, A., Cilio, C., Cedervall, E., Ivarsson, S.-A., Jónsdóttir, B., Jönsson, B., Larsson, K., Neiderud, J., Lernmark, Å., et al. (2013) · Pediatric Diabetes · doi:10.1111/pedi.12023 · Cited by 18
Klinke, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026873 · Cited by 17
Islet Volume and Indexes of β-Cell Function in Humans
Nano, R., Melzi, R., Mercalli, A., Balzano, G., Scavini, M., Bonadonna, R. C., & Piemonti, L. (2016) · Cell Transplantation · doi:10.3727/096368915x688498 · Cited by 4
Cited by
Extracellular vesicles as tools and targets in therapy for diseases
Kumar, M. A., Baba, S. K., Sadida, H. Q., Marzooqi, S. A., Jerobin, J., Altemani, F. H., Algehainy, N., Alanazi, M. A., Abou-Samra, A.-B., Kumar, R., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01735-1 · Cited by 1,343
Ahmad, E., Lim, S., Lamptey, R., Webb, D. R., & Davies, M. J. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01655-5 · Cited by 1,120
Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?)
Roep, B. O., Thomaidou, S., van Tienhoven, R., & Zaldumbide, A. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00443-4 · Cited by 623
From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Gastaldelli, A., & Cusi, K. (2019) · JHEP Reports · doi:10.1016/j.jhepr.2019.07.002 · Cited by 455
Tan, S. Y., Mei Wong, J. L., Sim, Y. J., Wong, S. S., Mohamed Elhassan, S. A., Tan, S. H., Ling Lim, G. P., Rong Tay, N. W., Annan, N. C., Bhattamisra, S. K., et al. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2018.10.008 · Cited by 445
Metadata
- Authors
- Chen, C., Cohrs, C. M., Stertmann, J., Bozsak, R., & Speier, S.
- Venue
- Molecular Metabolism
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 6
- Issue
- 9
- Pages
- 943-957
- ISSN
- 2212-8778 (ISSN-L)
- OpenAlex
- W2733324404
- Cited by
- 489
- References
- 221
- FWCI
- 39.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.